bismuth has been researched along with ciprofloxacin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 10 (43.48) | 2.80 |
| Authors | Studies |
|---|---|
| Dent, J; McNulty, CA; Wise, R | 1 |
| Gallicano, K; Garber, G; Oliveras, L; Rambout, L; Sahai, J | 1 |
| Coyle, W; Dresner, D; Duntemann, T; Lawson, JM; Nemec, R; Peterson, R | 1 |
| Bukovec, N; Leban, I; Turel, I | 1 |
| Bukovec, P; Golic, L; Gubina, M; Turel, I | 1 |
| Furne, JK; Levitt, MD; Madoff, RD; Ohge, H; Springfield, J; Sueda, T | 1 |
| Dunzendorfer, T; Johnson, R; Wilkins, S | 1 |
| Guan, W; Liu, X; Shi, W; Song, Y; Sun, S; Yan, X; Yan, Y | 1 |
| Li, H; Qiu, J; Xia, J; Xu, L; Xu, Q; Yan, P; Yuan, S; Zhang, S | 1 |
| Hernández-Uresti, DB; Obregón, S; Ruíz-Gómez, MA | 1 |
| Cao, J; Cen, Y; Ding, Y; Hu, Y; Huang, J; Tang, H | 1 |
| Chen, H; Ding, X; Li, S; Lu, Z; Wang, P; Xu, X; Yang, X | 1 |
| Alves, BG; de Magalhães Rodrigues Martins, CM; Dos Santos, MV; Feckinghaus, MA; Monteiro, CP; Paranhos, LG; Pinheiro, ESC | 1 |
| Haghighi, M; Mohseni, N; Shabani, M | 1 |
| Barańska, A; Drop, B; Gładysz, A; Kowalczuk, D; Miazga-Karska, M; Warda, P | 1 |
| Barańska, A; Drop, B; Gładysz, A; Kamiński, DM; Kowalczuk, D; Pitucha, M | 1 |
| Chen, Q; Ju, X; Liu, C; Mao, S; Shi, M; Wang, F; Xia, M | 1 |
| Chen, Z; Gu, C; Huang, L; Li, C; Mi, N; Teng, Y; Wang, W | 1 |
| Cheng, H; Dai, Y; Huang, B; Liu, Y; Qin, X; Wang, P; Wang, Z; Zhang, Q; Zhang, X; Zheng, Z | 1 |
| Balakumar, V; Chuaicham, C; Katsurao, T; Ohtani, B; Sakabe, H; Sasaki, K; Sekar, K; Uchida, J | 1 |
| Chen, Z; Ji, M; Li, H; Liu, Z; Nkudede, E; Shao, Y; Sun, X; Xia, J; Yin, S; Zhao, J | 1 |
| Huang, J; Jiang, L; Li, X; Yi, K; Yu, H; Yuan, X; Zhang, C | 1 |
| Bao, Y; Choong, ZY; He, C; Jaafar, NF; Koo, PL; Oh, WD | 1 |
3 trial(s) available for bismuth and ciprofloxacin
| Article | Year |
|---|---|
Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Bismuth; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Organometallic Compounds; Salicylates | 1994 |
Efficacy of ciprofloxacin in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1996 |
Noninferiority field trial for evaluation of efficacy of ciprofloxacin associated with internal teat sealant as dry-off protocol.
Topics: Animals; Anti-Bacterial Agents; Bismuth; Brazil; Cattle; Cephalosporins; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Female; Incidence; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Prevalence; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus | 2019 |
20 other study(ies) available for bismuth and ciprofloxacin
| Article | Year |
|---|---|
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cefoxitin; Ciprofloxacin; Erythromycin; Gastritis; Gentamicins; Humans; Metronidazole; Nalidixic Acid; Organometallic Compounds; Penicillin Resistance; Penicillins; Quinolines; Sulfamethoxazole; Tartrates; Trimethoprim | 1985 |
Crystal structure and characterization of the bismuth(III) compound with quinolone family member (ciprofloxacin). Antibacterial study.
Topics: Anti-Infective Agents; Bismuth; Ciprofloxacin; Crystallography, X-Ray; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Organometallic Compounds; Spectroscopy, Fourier Transform Infrared | 1997 |
Antibacterial tests of bismuth(III)-quinolone (ciprofloxacin, cf) compounds against Helicobacter pylori and some other bacteria. Crystal structure of (cfH2)2[Bi2Cl10].4H2O.
Topics: Anti-Infective Agents; Bismuth; Ciprofloxacin; Crystallography, X-Ray; Enterococcus; Fluoroquinolones; Helicobacter pylori; Hydrogen Bonding; Microbial Sensitivity Tests; Models, Molecular; Organometallic Compounds; Streptococcus; Structure-Activity Relationship | 1998 |
The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat.
Topics: Animals; Antacids; Anti-Infective Agents; Bacteria; Bismuth; Ciprofloxacin; Colon; Feces; Hydrogen Sulfide; Male; Metronidazole; Rats; Rats, Sprague-Dawley; Sulfasalazine; Sulfates | 2003 |
Mucosal tear in collagenous colitis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antidiarrheals; Biopsy; Bismuth; Budesonide; Ciprofloxacin; Colitis, Collagenous; Colonoscopy; Enema; Female; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 2009 |
Microwave-assisted in situ synthesis of reduced graphene oxide-BiVO4 composite photocatalysts and their enhanced photocatalytic performance for the degradation of ciprofloxacin.
Topics: Absorption; Bismuth; Catalysis; Ciprofloxacin; Electrons; Graphite; Light; Microscopy, Electron, Transmission; Microwaves; Nanoparticles; Oxides; Photochemistry; Spectrum Analysis, Raman; Vanadates; X-Ray Diffraction | 2013 |
Graphitic carbon nitride/BiOCl composites for sensitive photoelectrochemical detection of ciprofloxacin.
Topics: Anti-Bacterial Agents; Bismuth; Calibration; Ciprofloxacin; Electrochemical Techniques; Graphite; Humans; Ionic Liquids; Kinetics; Limit of Detection; Nitriles; Photochemical Processes; Water Pollutants, Chemical | 2016 |
Direct evidence of the photocatalytic generation of reactive oxygen species (ROS) in a Bi
Topics: Bismuth; Catalysis; Ciprofloxacin; Hydroxyl Radical; Light; Molecular Structure; Nanostructures; Oxidation-Reduction; Oxides; Particle Size; Photochemical Processes; Reactive Oxygen Species; Surface Properties; Temperature; Tungsten | 2017 |
Variable-valence metals catalyzed solid NaBiO
Topics: Bismuth; Catalysis; Ciprofloxacin; Metals; Nanostructures; Norfloxacin; Ofloxacin; Oxidation-Reduction; Oxidative Stress; Oxygen; Sodium; X-Ray Diffraction | 2018 |
Oxygen vacancy boosted photocatalytic decomposition of ciprofloxacin over Bi
Topics: Anti-Infective Agents; Bismuth; Catalysis; Ciprofloxacin; Escherichia coli; Light; Molybdenum; Oxygen; Photolysis; Saccharomyces cerevisiae | 2019 |
Sunlight-activated 3D-mesoporous-flowerlike Cl-Br bismuth oxides nanosheet solid solution: In situ EG-thermal-sonication synthesis with excellent photodecomposition of ciprofloxacin.
Topics: Bismuth; Catalysis; Ciprofloxacin; Light; Oxides; Pharmaceutical Preparations; Sonication; Sunlight | 2020 |
Characterization of Ciprofloxacin-Bismuth-Loaded Antibacterial Wound Dressing.
Topics: Anti-Bacterial Agents; Bandages; Bismuth; Ciprofloxacin; Escherichia coli; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 2020 |
Spectroscopic Study of the Molecular Structure of the New Hybrid with a Potential Two-Way Antibacterial Effect.
Topics: Anti-Bacterial Agents; Bismuth; Chlorhexidine; Ciprofloxacin; Coordination Complexes; Magnetic Resonance Spectroscopy; Molecular Structure; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2021 |
Peroxymonosulfate activation through 2D/2D Z-scheme CoAl-LDH/BiOBr photocatalyst under visible light for ciprofloxacin degradation.
Topics: Bismuth; Ciprofloxacin; Coal; Light; Peroxides | 2021 |
Snow-like BiVO
Topics: Bismuth; Catalysis; Ciprofloxacin; Light; Oxygen | 2022 |
A biocompatible bismuth based metal-organic framework as efficient light-sensitive drug carrier.
Topics: Bismuth; Ciprofloxacin; Drug Carriers; Metal-Organic Frameworks; Tetracycline | 2022 |
Efficient photocatalytic degradation of emerging ciprofloxacin under visible light irradiation using BiOBr/carbon quantum dot/saponite composite.
Topics: Aluminum Silicates; Bismuth; Carbon; Catalysis; Ciprofloxacin; Clay; Light; Quantum Dots; Wastewater | 2022 |
Oxygen vacancy triggering the broad-spectrum photocatalysis of bismuth oxyhalide solid solution for ciprofloxacin removal.
Topics: Bismuth; Catalysis; Ciprofloxacin; Oxygen; Sunlight | 2022 |
Construction of PDIsa/BiOBr type-I scheme heterojunction for efficient ciprofloxacin photocatalytic degradation.
Topics: Bismuth; Catalysis; Ciprofloxacin | 2023 |
Effect of metal doping (Me = Zn, Cu, Co, Mn) on the performance of bismuth ferrite as peroxymonosulfate activator for ciprofloxacin removal.
Topics: Bismuth; Ciprofloxacin; Oxygen; Peroxides; Water; Zinc | 2023 |